Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 572 for sleep

Edit search filters
  1. A Study Comparing Sublobar Resection versus Stereotactic Ablative Radiotherapy for Lung Cancer

  2. MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

  3. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

    Rochester, MN

  4. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM

    Rochester, MN

  5. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  6. PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

    Scottsdale/Phoenix, AZ

  7. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  9. An Extension Study Assessing the Long-Term Safety, Tolerability, and Effectiveness of Liposomal Amikacin Inhalant in Patients with Non-Tuberculous Mycobacterial Lung Infections, Who Participated in Study INS-212

    Rochester, MN

  10. Ruxolitinib in Combination with Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer